Currently, AChE inhibitors, including Donepezil (Aricept®), Galantamine (GNT) (Reminyl®) (Figure 1), and Rivastigmine (Exelon®), are widely used in symptomatic treatments for AD. This evidence concerns the gene ACHE and Alzheimer disease.